Urocortin 1 and 3 impair maternal defense behavior in mice

Behavioral Neuroscience

Volumn 119, Issue 4, 2005, Pages 1061-1071

  D'Anna, Kimberly L ^a   Stevenson, Sharon A ^a   Gammie, Stephen C ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Bed nucleus of the stria terminalis; Corticotropin releasing factor; Corticotropin releasing factor receptor 2; Lateral septum; Maternal aggression

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR 2; PROTEIN C FOS; UNCLASSIFIED DRUG; UROCORTIN; UROCORTIN 1; UROCORTIN III;

AGGRESSION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTICLE; BED NUCLEUS OF STRIA TERMINALIS; CONTROLLED STUDY; DEFENSIVE BEHAVIOR; FEAR; FEMALE; LACTATION; MATERNAL BEHAVIOR; MOUSE; MOUSE STRAIN; NONHUMAN; SEPTUM PELLUCIDUM; STRIA TERMINALIS;

AGGRESSION; ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; CELL COUNT; CORTICOTROPIN-RELEASING HORMONE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; INJECTIONS, INTRAVENTRICULAR; MATERNAL BEHAVIOR; MICE; MICE, INBRED ICR; PROTO-ONCOGENE PROTEINS C-FOS; SEPTAL NUCLEI;

EID: 25444495634     PISSN: 07357044     EISSN: None     Source Type: Journal    
DOI: 10.1037/0735-7044.119.4.1061     Document Type: Article

References (48)

1. Bakshi, V. P., Smith-Roe, S., Newman, S. M., Grigoriadis, D. E., & Kalin, N. H. (2002). Reduction of stress-induced behavior by antagonism of corticotropin-releasing hormone 2 (CRH2) receptors in lateral septum or CRH1 receptors in amygdala. Journal of Neuroscience, 22, 2926-2935.
2. Bale, T. L., Picetti, R., Contarino, A., Koob, G. F., Vale, W. W., & Lee, K. F. (2002). Mice deficient for both corticotropin-releasing factor receptor 1 (CRFR1) and CRFR2 have an impaired stress response and display sexually dichotomous anxiety-like behavior. Journal of Neuroscience, 11, 193-199.
3. Chalmers, D., Lovenberg, T., & De Souza, E. (1995). Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: Comparison with CRF1 receptor mRNA expression. Journal of Neuroscience, 15, 6340-6350.
4. Clement, C., Keay, K., Owler, B., & Bandler, R. (1996). Common patterns of increased and decreased Fos expression in midbrain and pons evoked by noxious deep somatic and noxious visceral manipulations in the rat. Journal of Comparative Neurology, 366, 495-515.
5. Dabney, A., & Storey, J. D. (2002). QVALUE [Computer software]. Retrieved from http://faculty.washington.edu/~jstorey/qvalue/.
6. da Costa, A. P., Kampa, R. J., Windle, R. J., Ingram, C. D., & Lightman, S. L. (1997). Region-specific immediate-early gene expression following the administration of corticotropin-releasing hormone in virgin and lactating rats. Brain Research, 770(1-2), 151-162.
7. Ferreira, A., Pereira, M., Agrati, D., Uriarte, N., & Fernandez-Guasti, A. (2002). Role of maternal behavior on aggression, fear and anxiety. Physiology & Behavior, 77(2-3), 197-204.
8. Fleming, A. S., & Luebke, C. (1981). Timidity prevents the virgin female rat from being a good mother: Emotionality differences between nulliparous and parturient females. Physiology & Behavior, 27, 863-868.
9. Gammie, S. C., Hasen, N. S., Stevenson, S. A., Bale, T. L., & D'Anna, K. L. (2005). Elevated stress sensitivity in corticotropin-releasing factor 2 mice decreases maternal, but not intermale aggression. Behavioural Brain Research.
10. Gammie, S. C., Huang, P. L., & Nelson, R. J. (2000). Maternal aggression in endothelial nitric oxide synthase-deficient mice. Hormones & Behavior, 38, 13-20.
11. Gammie, S. C., Negron, A., Newman, S. M., & Rhodes, J. S. (2004). Corticotropin-releasing factor inhibits maternal aggression in mice. Behavioral Neuroscience, 118, 805-814.
12. Gammie, S. C., & Nelson, R. J. (1999). Maternal aggression is reduced in neuronal nitric oxide synthase-deficient mice. Journal of Neuroscience, 19, 8027-8035.
13. Gammie, S. C., & Nelson, R. J. (2001). cFOS and pCREB activation and maternal aggression in mice. Brain Research, 898, 232-241.
14. Hammack, S. E., Richey, K. J., Schmid, M., LoPresti, M., Watkins, L., & Maier, S. (2001). The role of corticotopin releasing hormone in the dorsal raphe nucleus in mediating the behavioral consequences of uncontrollable stress. Journal of Neuroscience, 22, 1020-1026.
15. Hammack, S. E., Richey, K. J., Schmid, M. J., LoPresti, M. L., Watkins, L. R., & Maier, S. F. (2003). Low doses of corticotropin-releasing hormone injected in to the dorsal raphe nucleus block the behavioral consequences of uncontrollable stress. Behavioural Brain Research, 147, 55-64.
16. Hammack, S. E., Schmid, M., LoPresti, M., Der-Avakian, A., Pelleymounter, M., Foster, A., et al. (2003). Corticotropin releasing hormone type 2 receptors in the dorsal raphe nucleus mediate the behavioral consequences of uncontrollable stress. Journal of Neuroscience, 23, 1019-1025.
17. Hard, E., & Hansen, S. (1985). Reduced fearfulness in the lactating rat. Physiology & Behavior, 35, 641-643.
18. Hasen, N. H., & Gammie, S. C. (2005). Differential fos activation in virgin and lactating mice in response to an intruder. Physiology & Behavior, 84, 681-695.
19. Hauger, R., Grigoriadis, D., Dallman, M., Plotsky, P., Vale, W., & Dautzenberg, F. (2003). International Union of Pharmacology: XXXVI. Current status of the nomenclature for receptors for corticotropin-releasing factor and their ligands. Pharmacological Reviews, 55, 21-26.
20. Hsu, S., & Hsueh, A. (2001). Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor. Nature Medicine, 7, 605-611.
21. Kellogg, C. K., & Barrett, K. A. (1999). Reduced progesterone metabolites are not critical for plus-maze performance of lactating female rats. Pharmacology Biochemistry and Behavior, 63, 441-448.
22. Keppel, G. (1991). Design and analysis: A researcher's handbook (3rd ed.). Upper Saddle River, NJ: Prentice Hall.
23. Koob, G. F., & Heinrichs, S. C. (1999). A role for corticotropin releasing factor and urocortin in behavioral responses to stressors. Brain Research, 848(1-2), 141-152.
24. Kozicz, T., Yanaihara, H., & Arimura, A. (1998). Distribution of urocortin-like immunoreactivity in the central nervous system of the rat. Journal of Comparative Neurology, 391, 1-10.
25. Lee, Y., & Davis, M. (1997). Role of hippocampus, the bed nucleus of the stria terminalis, and the amygdala in the excitatory effect of corticotropin-releasing hormone on the acoustic startle reflex. Journal of Neuroscience, 17, 6434-6446.
26. Lewis, K., Li, C., Perrin, M. H., Blount, A., Kunitake, K., Donaldson, C., et al. (2001). Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor. Proceedings of the National Academy of Sciences, USA, 98, 7570-7575.
27. Li, C., Vaughan, J., Sawchenko, P. E., & Vale, W. W. (2002). Urocortin III-immunoreactive projections in rat brain: Partial overlap with sites of type 2 corticotrophin-releasing factor receptor expression. Journal of Neuroscience, 22, 991-1001.
28. Lonstein, J. S., & Gammie, S. C. (2002). Sensory, hormonal, and neural control of maternal aggression in laboratory rodents. Neuroscience and Biobehavioral Reviews, 26, 869-888.
29. Maestripieri, D., Badiani, A., & Puglisi-Allegra, S. (1991). Prepartal chronic stress increases anxiety and decreases aggression in lactating female mice. Behavioral Neuroscience, 105, 663-668.
30. Menard, J., & Treit, D. (1996). Lateral and medial septal lesions reduce anxiety in the plus-maze and probe-burying tests. Physiology & Behavior, 60, 845-853.
31. Moreau, J., Kilpatrick, G., & Jenck, F. (1997). Urocortin, a novel neuropeptide with anxiogenic-like properties. Neuroreport, 8, 1697-1701.
32. Pelleymounter, M., Joppa, M., Ling, N., & Foster, A. (2004). Behavioral and neuroendocrine effects of the selective CRF2 receptor agonists urocortin I and urocortin III. Peptides, 25, 659-666.
33. Picazo, O., & Fernandez-Guasti, A. (1993). Changes in experimental anxiety during pregnancy and lactation. Physiology & Behavior, 54, 295-299.
34. Radulovic, J., Rühmann, A., Liepold, T., & Spiess, J. (1999). Modulation of learning and anxiety by corticotropin-releasing factor (CRF) and stress: Differential roles of CRF receptors 1 and 2. Journal of Neuroscience, 19, 5016-5025.
35. Rhodes, J. S., Ryabinin, A., & Crabbe, J. (2005). Patterns of brain activation associated with contextual conditioning to methamphetamine in mice. Behavioral Neuroscience. 119, 759-771.
36. Sinnayah, P., Blair-West, J., McBurnie, M., McKinley, M., Oldfield, B., Rivier, J., et al. (2003). The effect of urocortin on ingestive behaviours and brain Fos immunoreactivity in mice. European Journal of Neuroscience, 18, 373-382.
37. Spina, G., Merlo-Pich, E., Akwa, Y., Balducci, C., Basso, M., Zorrilla, P., et al. (2002). Time-dependent induction of anxiogenic-like effects after central infusion of urocortin or corticotropin-releasing factor in the rat. Psychopharmacology, 160, 113-121.
38. Storey, J. D. (2002). A direct approach to false discovery rates. Journal of the Royal Statistical Society, Series B, 64, 479-498.
39. Svare, B. (1990). Maternal aggression: Hormonal, genetic, and developmental determinants. In N. A. Krasnegor & R. S. Bridges (Eds.), Mammalian parenting: Biochemical, neurobiological, and behavioral determinants (pp. 118-132). New York: Oxford University Press.
40. Svare, B., Betteridge, C., Katz, D., & Samuels, O. (1981). Some situational and experiential determinants of maternal aggression in mice. Physiology & Behavior, 26, 253-258.
41. Takahashi, L., Ho, S., Livanov, V., Graciani, N., & Arneric, S. (2001). Antagonism of CRF2 receptors produces anxiolytic behavior in animal models of anxiety. Brain Research, 902, 135-142.
42. Toufexis, D. J., Rochford, J., & Walker, C. D. (1999). Lactation-induced reduction in rats' acoustic startle is associated with changes in noradrenergic neurotransmission. Behavioral Neuroscience, 113, 176-184.
43. Valdez, G., Zorrilla, E., Rivier, J., Vale, W., & Koob, G. (2003). Locomotor suppressive and anxiolytic-like effects of urocortin 3, a highly selective type 2 corticotropin-releasing factor agonist. Brain Research, 980, 206-212.
44. van Luijtelaar, G., Fabene, P., de Bruin, N., Jongema, C., Ellenbroek, B., & Veening, J. (2001). Neural correlates of sensory gating in the rat: Decreased Fos induction in the lateral septum. Brain Research Bulletin, 54(2), 145-151.
45. Vaughan, J., Donaldson, C., Bittencourt, J., Perrin, M. H., Lewis, K., Sutton, S., et al. (1995). Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature, 378, 287-292.
46. Venihaki, M., Sakihara, S., Subramanian, S., Dikkes, P., Weninger, S., Liapakis, G., et al. (2004). Urocortin III, a brain neuropeptide of the corticotropin-releasing hormone family: Modulation by stress and attenuation of some anxiety-like behaviours. Journal of Neuroendocrinology, 16, 411-422.
47. Walker, C., Toufexis, D., & Burlet, A. (2001). Hypothalamic and limbic expression of CRF and vasopressin during lactation: Implications for the control of ACTH secretion and stress hyporesponsiveness. Progress in Brain Research, 133, 99-110.
48. Walker, D., Toufexis, D., & Davis, M. (2003). Role of the bed nucleus of the stria terminalis versus the amygdala in fear, stress and anxiety. European Journal of Pharmacology, 463, 199-216.